GlassScriptPhysician profile
Boyd A Dwyer
NPI 1134123615
$214,106.94
in general payments reported to CMS, 2019-2025
77 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $38K · 2021: $41K · 2022: $33K · 2023: $56K · 2024: $32K · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61K · Travel and Lodging: $14K · Food and Beverage: $7,858 · Consulting Fee: $5,665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $61,203.75 |
| Travel and Lodging | $13,894.82 |
| Food and Beverage | $7,858.28 |
| Consulting Fee | $5,665.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $70,268.65 | 2019-2025 | Ubrelvy, Qulipta, Botox |
| Alnylam Pharmaceuticals INC. | $59,136.32 | 2019-2025 | Amvuttra, Onpattro |
| Allergan, INC. | $42,551.56 | 2019-2022 | |
| Genzyme Corporation | $23,803.06 | 2019-2023 | |
| Akcea Therapeutics, INC. | $3,322.47 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $1,293.83 | 2019-2025 | |
| Banner Life Sciences, LLC | $1,004.94 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $876.20 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Amgen INC. | $706.65 | 2019-2024 | Aimovig |
| Lilly USA, LLC | $679.94 | 2019-2025 | Emgality, Reyvow, Amyvid |
| Supernus Pharmaceuticals, INC. | $672.96 | 2019-2022 | |
| Biogen, INC. | $548.38 | 2019-2025 | Vumerity, Tysabri, Spinraza |
| Ucb, INC. | $514.23 | 2019-2024 | Briviact, Rystiggo, Zilbrysq |
| Emd Serono, INC. | $484.77 | 2019-2025 | Mavenclad |
| Lundbeck LLC | $462.10 | 2019-2025 | Vyepti, Rexulti |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $405.59 | 2019-2022 | |
| Neurelis, INC. | $368.73 | 2020-2025 | Valtoco |
| Acadia Pharmaceuticals INC | $357.33 | 2019-2025 | Nuplazid |
| Genentech USA, INC. | $351.98 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Neurocrine Biosciences, INC. | $304.79 | 2019-2024 | Ingrezza, Ongentys |
| Alexion Pharmaceuticals, INC. | $288.30 | 2019-2023 | Ultomiris |
| Eisai INC. | $286.47 | 2019-2025 | |
| Acorda Therapeutics, INC | $273.28 | 2019-2024 | Ampyra, Inbrija |
| Pfizer INC. | $252.78 | 2021-2024 | |
| Tanabe Pharma America, INC. | $240.50 | 2019-2025 | Radicava |
| Kyowa Kirin, INC. | $228.49 | 2020-2024 | Nourianz |
| Celgene Corporation | $225.82 | 2020-2024 | Zeposia |
| Upsher-Smith Laboratories LLC | $220.49 | 2019-2022 | |
| Mdd US Operations, LLC | $213.83 | 2020-2024 | Gocovri, Gocovri |
| Mallinckrodt Hospital Products INC. | $201.38 | 2020-2025 | Acthar |
| Argenx US, INC. | $200.27 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Jazz Pharmaceuticals INC. | $196.29 | 2020-2024 | |
| Amneal Pharmaceuticals LLC | $186.42 | 2019-2025 | Rytary, Ongentys |
| Harmony Biosciences LLC | $160.20 | 2020-2025 | |
| Currax Pharmaceuticals LLC | $152.85 | 2020-2024 | Onzetra Xsail, Contrave |
| Sumitomo Pharma America, INC. | $128.81 | 2023-2024 | Aptiom |
| Scilex Pharmaceuticals INC. | $117.79 | 2023-2025 | Ztlido |
| Adamas Pharmaceuticals, INC. | $117.71 | 2019-2021 | |
| Azurity Pharmaceuticals, INC. | $112.85 | 2023-2024 | Horizant, Horizant |
| Avanir Pharmaceuticals, INC. | $109.44 | 2019-2022 | |
| Csl Behring | $108.68 | 2019-2024 | Hizentra |
| Horizon Therapeutics Plc | $103.16 | 2021-2023 | Uplizna |
| Grifols USA, LLC | $98.94 | 2019-2024 | Gamunex-C |
| Otsuka America Pharmaceutical, INC. | $97.43 | 2023-2024 | Nuedexta, Rexulti |
| Impel Pharmaceuticals INC. | $92.75 | 2022-2023 | Trudhesa |
| Amylyx Pharmaceuticals, INC. | $91.57 | 2023-2024 | Relyvrio |
| Ani Pharmaceuticals, INC. | $89.48 | 2022-2023 | Purified Cortrophin Gel |
| Sk Life Science, INC. | $87.21 | 2021-2023 | |
| Axsome Therapeutics, INC. | $84.02 | 2023-2025 | Sunosi |
| Biohaven Pharmaceuticals, INC. | $82.87 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $78.31 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $71.88 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $69.67 | 2022 | |
| Merz Pharmaceuticals, LLC | $67.17 | 2023 | Xeomin |
| Livanova USA, INC. | $66.73 | 2019-2022 | |
| Assertio Therapeutics, INC. | $63.61 | 2019-2020 | |
| Avion Pharmaceuticals | $63.38 | 2022-2023 | Dhivy |
| Vanda Pharmaceuticals INC. | $59.61 | 2024-2025 | Ponvory |
| Merck Sharp & Dohme LLC | $57.27 | 2021-2023 | Belsomra |
| Promius Pharma LLC | $56.63 | 2019 | |
| Collegium Pharmaceutical, INC. | $56.34 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $46.87 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $45.48 | 2019 | |
| Ge Healthcare | $45.11 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $40.26 | 2023 | Quviviq |
| Corium, LLC | $40.03 | 2023 | Adlarity |
| Greenwich Biosciences, INC. | $30.99 | 2019-2021 | |
| Almatica Pharma LLC | $29.95 | 2021-2023 | Gralise |
| Medtronic, INC. | $26.20 | 2023 | Vanta Adaptivestim |
| Ironshore Pharmaceuticals INC. | $23.88 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.70 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $16.53 | 2024 | Lumryz |
| Invivyd INC | $16.09 | 2024 | Pemgarda |
| Life Molecular Imaging LTD | $15.08 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.83 | 2020 | |
| Medtronic USA, INC. | $12.23 | 2019 | |
| Abbott Laboratories | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boyd Dwyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.